Habib Dable

Habib Dable

Director/Board Member at PEPGEN INC.

Net worth: - $ as of 31/05/2026

56 year
Health Technology
Commercial Services
Consumer Services

Profile

Presently, Habib J. Dable is President, Chief Executive Officer & Director at Acceleron Pharma, Inc. He previously occupied the position of President-US Pharmaceuticals at Bayer AG and EVP & Global Head- Specialty Medicine at Bayer HealthCare Pharmaceuticals, Inc. (a subsidiary of Bayer AG). He received an MBA and an undergraduate degree from the University of New Brunswick.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/06/2026 0 ( -.--% ) - $ 31/05/2026
16/04/2026 0 ( -.--% ) - $ 31/05/2026
31/03/2026 0 ( -.--% ) - $ 31/05/2026
05/02/2026 0 ( -.--% ) - $ 31/05/2026

Habib Dable active positions

CompaniesPositionStart
PEPGEN INC. Director/Board Member 22/09/2022
RELAY THERAPEUTICS, INC. Director/Board Member 04/11/2025
SPYGLASS PHARMA, INC. Director/Board Member 05/02/2026
TYRA BIOSCIENCES, INC. Director/Board Member 16/04/2026
Corporate Officer/Principal -

Former positions of Habib Dable

CompaniesPositionEnd
DAY ONE BIOPHARMACEUTICALS, INC. Director/Board Member 23/04/2026
BLUEPRINT MEDICINES CORPORATION Director/Board Member 17/07/2025
JADE BIOSCIENCES, INC. Chairman 28/04/2025
ALBIREO PHARMA, INC. Director/Board Member 02/03/2023
░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Habib Dable's experience

Training of Habib Dable

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

61

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!